These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 36279666

  • 1. Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma.
    Li S, Pi G, Zeng Y, Ruan C, He X, Xiong X, Zhang M, Zou J, Liang X.
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109323. PubMed ID: 36279666
    [Abstract] [Full Text] [Related]

  • 2. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis.
    Zhao J, Cui L, Sun J, Xie Z, Zhang L, Ding Z, Quan X.
    Cell Signal; 2020 Dec; 76():109781. PubMed ID: 32947021
    [Abstract] [Full Text] [Related]

  • 3. Notoginsenoside R1 protects WI-38 cells against lipopolysaccharide-triggered injury via adjusting the miR-181a/TLR4 axis.
    Qian D, Shao X, Li Y, Sun X.
    J Cell Biochem; 2019 Dec; 120(12):19764-19774. PubMed ID: 31297873
    [Abstract] [Full Text] [Related]

  • 4. Notoginsenoside R1 up-regulates microRNA-132 to protect human lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury.
    Cong S, Xiang L, Yuan X, Bai D, Zhang X.
    Int Immunopharmacol; 2019 Mar; 68():137-144. PubMed ID: 30622031
    [Abstract] [Full Text] [Related]

  • 5. Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88.
    Zhang J, Zheng Q, Lu H, Jin F, Li Y, Bi F, Xu J.
    Int J Immunopathol Pharmacol; 2019 Mar; 33():2058738419857550. PubMed ID: 31204533
    [Abstract] [Full Text] [Related]

  • 6. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
    Zhu L, Gong X, Gong J, Xuan Y, Fu T, Ni S, Xu L, Ji N.
    Braz J Med Biol Res; 2020 Mar; 53(6):e9346. PubMed ID: 32401923
    [Abstract] [Full Text] [Related]

  • 7. Notoginsenoside R1 alleviates high glucose-induced inflammation and oxidative stress in HUVECs via upregulating miR-147a.
    Li XQ, Huang TY.
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1101-1112. PubMed ID: 34369659
    [Abstract] [Full Text] [Related]

  • 8. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y, Feng G, Wu L, Zhong S, Gao X, Tong Y, Cui W, Qin Y, Xu W, Xiao X, Zhang Z, Huang G, Zhou X.
    Drug Des Devel Ther; 2019 Dec; 13():1335-1345. PubMed ID: 31118570
    [Abstract] [Full Text] [Related]

  • 9. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR, Wang SL, Wang M, Sun LM.
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [Abstract] [Full Text] [Related]

  • 10. Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K/AKT/NF-κB pathway.
    Zhan Q, Wu Y, Liu L.
    Drug Dev Res; 2022 Feb; 83(1):97-104. PubMed ID: 34173680
    [Abstract] [Full Text] [Related]

  • 11. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132.
    Fu C, Yin D, Nie H, Sun D.
    Cell Physiol Biochem; 2018 Feb; 51(4):1739-1750. PubMed ID: 30504696
    [Abstract] [Full Text] [Related]

  • 12. Lupeol triggers oxidative stress, ferroptosis, apoptosis and restrains inflammation in nasopharyngeal carcinoma via AMPK/NF-κB pathway.
    Zhou JC, Wu B, Zhang JJ, Zhang W.
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):621-631. PubMed ID: 35486494
    [Abstract] [Full Text] [Related]

  • 13. Notoginsenoside R1 ameliorates the inflammation induced by amyloid‑β by suppressing SphK1‑mediated NF‑κB activation in PC12 cells.
    Wang X, Li B, Yu X, Zhou Y, Wang K, Gao Y.
    Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38063180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways.
    Meng X, Wang M, Wang X, Sun G, Ye J, Xu H, Sun X.
    Free Radic Res; 2014 Jul; 48(7):823-38. PubMed ID: 24720662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell.
    Li CH, Ding H, Shi JL, Huang B, Ding H, Lin HG, Zeng JC, Zhao Y, Luo GQ.
    J Tradit Chin Med; 2021 Jun; 41(3):367-375. PubMed ID: 34114393
    [Abstract] [Full Text] [Related]

  • 20. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
    Huang XP, Ding H, Lu JD, Tang YH, Deng BX, Deng CQ.
    Am J Chin Med; 2015 Jun; 43(7):1419-38. PubMed ID: 26477799
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.